» Articles » PMID: 22870943

Active Induction of Experimental Autoimmune Encephalomyelitis by MOG35-55 Peptide Immunization is Associated with Differential Responses in Separate Compartments of the Choroid Plexus

Overview
Publisher Biomed Central
Date 2012 Aug 9
PMID 22870943
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled:

Background: There is increasing awareness that, aside from producing cerebrospinal fluid, the choroid plexus (CP) might be a key regulator of immune activity in the central nervous system (CNS) during neuroinflammation. Specifically, the CP has recently been posited to control entry of sentinel T cells into the uninflamed CNS during the early stages of neuroinflammatory diseases, like multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). As the CP is compartmentalized into a stromal core containing fenestrated capillaries devoid of typical blood-brain barrier properties, surrounded by a tight junction-expressing choroidal epithelium, each of these compartments might mount unique responses that instigate the neuroinflammatory process.

Methods: To discern responses of the respective CP stromal capillary and choroidal epithelial tissues during evolving neuroinflammation, we investigated morphology and in situ expression of 93 immune-related genes during early stages of EAE induced by immunization with myelin oligodendrocyte glycoprotein peptide (MOG35-55). Specifically, 3-D immunofluorescent imaging was employed to gauge morphological changes, and laser capture microdissection was coupled to an Immune Panel TaqMan Low Density Array to detail alterations in gene expression patterns at these separate CP sites on days 9 and 15 post-immunization (p.i.). To resolve CP effects due to autoimmunity against MOG peptide, from those due to complete Freund's adjuvant (CFA) and pertussis toxin (PTX) included in the immunization, analysis was performed on MOG-CFA/PTX-treated, CFA/PTX-treated, and naïve cohorts.

Results: The CP became swollen and displayed significant molecular changes in response to MOG-CFA/PTX immunization. Both stromal capillary and choroidal epithelial tissues mounted vigorous, yet different, changes in expression of numerous genes over the time course analyzed - including those encoding adhesion molecules, cytokines, chemokines, statins, interleukins, T cell activation markers, costimulatory molecules, cyclooxygenase, pro-inflammatory transcription factors and pro-apoptotic markers. Moreover, CFA/PTX-treatment, alone, resulted in extensive, though less robust, alterations in both CP compartments.

Conclusions: MOG-CFA/PTX immunization significantly affects CP morphology and stimulates distinct expression patterns of immune-related genes in CP stromal capillary and epithelial tissues during evolving EAE. CFA/PTX treatment, alone, causes widespread gene alterations that could prime the CP to unlock the CNS to T cell infiltration during neuroinflammatory disease.

Citing Articles

Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS.

Laaker C, Baenen C, Kovacs K, Sandor M, Fabry Z Front Immunol. 2023; 14:1233908.

PMID: 37662908 PMC: 10471710. DOI: 10.3389/fimmu.2023.1233908.


The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis.

Angelini G, Bani A, Constantin G, Rossi B Front Cell Neurosci. 2023; 17:1101379.

PMID: 36874213 PMC: 9975172. DOI: 10.3389/fncel.2023.1101379.


Advancing brain barriers RNA sequencing: guidelines from experimental design to publication.

Francisco D, Marchetti L, Rodriguez-Lorenzo S, Frias-Anaya E, Figueiredo R, Winter P Fluids Barriers CNS. 2020; 17(1):51.

PMID: 32811511 PMC: 7433166. DOI: 10.1186/s12987-020-00207-2.


Choroid plexus and the blood-cerebrospinal fluid barrier in disease.

Solar P, Zamani A, Kubickova L, Dubovy P, Joukal M Fluids Barriers CNS. 2020; 17(1):35.

PMID: 32375819 PMC: 7201396. DOI: 10.1186/s12987-020-00196-2.


Human CD4 T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro.

Nishihara H, Soldati S, Mossu A, Rosito M, Rudolph H, Muller W Fluids Barriers CNS. 2020; 17(1):3.

PMID: 32008573 PMC: 6996191. DOI: 10.1186/s12987-019-0165-2.


References
1.
Muzio L, Cavasinni F, Marinaro C, Bergamaschi A, Bergami A, Porcheri C . Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis. Mol Cell Neurosci. 2009; 43(3):268-80. DOI: 10.1016/j.mcn.2009.11.008. View

2.
Goverman J . Autoimmune T cell responses in the central nervous system. Nat Rev Immunol. 2009; 9(6):393-407. PMC: 2813731. DOI: 10.1038/nri2550. View

3.
Liddelow S, Temple S, Mollgard K, Gehwolf R, Wagner A, Bauer H . Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach. PLoS One. 2012; 7(3):e33554. PMC: 3310074. DOI: 10.1371/journal.pone.0033554. View

4.
Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, Tanaka Y . CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J Immunol. 2009; 183(4):2513-21. DOI: 10.4049/jimmunol.0800729. View

5.
Brown D, Sawchenko P . Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol. 2007; 502(2):236-60. DOI: 10.1002/cne.21307. View